E& Investment, a South Korean venture capital that specializes in the bio and health care sectors, said Thursday that NeuroBo Pharmaceutical, in which the company owns a 40 percent stake, had acquired a US COVID-19 treatment developer.
NeuroBo, a …
VIEW ARTICLE
If you would like to know more regarding the topic in this blog post, please do not hesitate to contact us.